SUBSCRIBE
SUBSCRIBE
News   Policy

Eli Lilly and Company (JOBS), Amylin Pharmaceuticals, Inc. Submit US Application for New Byetta

May 5, 2009 | 
1 min read

Bookmark and Share

Reuters -- Amylin Pharmaceuticals Inc and Eli Lilly and Co said on Tuesday they submitted a U.S. application seeking approval for a once-weekly form of their injected Byetta diabetes treatment.

Regulatory
Eli Lilly and Company
MORE ON THIS TOPIC
The EMA's former headquarters in London
Europe
Biogen, Eisai Continue Leqembi’s European Rally as CHMP Reaffirms Positive Opinion
March 3, 2025
 · 
2 min read
 · 
Tristan Manalac
Editorial
Transparency Missing in Action at HHS Despite Leaders’ Calls for Clarity
February 28, 2025
 · 
4 min read
 · 
Heather McKenzie
Pictured: Regeneron logo on a light brown building
Lymphoma
Regeneron Narrows Approval Aspirations for Lymphoma Bispecific, Citing ‘Competitor Developments’
February 27, 2025
 · 
2 min read
 · 
Tristan Manalac
Pictured: A syringe broken in half with long hallway in background/Nicole Bean for BioSpace
Vaccines
Meeting of FDA’s Vaccines Advisory Panel Canceled as Kennedy Settles Into HHS
February 27, 2025
 · 
2 min read
 · 
Tristan Manalac